In this podcast, Ned Flaxman – general manager UK for Krka – discusses how UK practice can optimise profitability, particularly with a focus on product sales. _____________________________ 𝗡𝗘𝗗 𝗙𝗟𝗔𝗫𝗠𝗔𝗡 Awarded a Royal Navy Bursary to complete a degree in Animal Sciences at London University, Ned served as a Seaman Officer for eight years in a variety roles, from diver to navigator. On leaving the armed forces he completed a self-funded one-year full-time MBA at the Cranfield School of Management, leading to a commercial management position at International Paints, the marine coatings division of Akzo Nobel. After three years he had the opportunity to transfer to the Veterinary Pharmaceuticals division of Akzo Nobel and so began his 20-plus year career in the Animal Health industry returning to his university degree roots. During this time Ned has held a number of senior commercial roles with category leading businesses including Pfizer and Pets at Home. In 2017 Ned embraced the opportunity to leverage his industry experience as UK Country Manager for the European generic pharmaceutical company Krka, building a solid and growing market position for the brand in the UK, under his leadership. _____________________________ 𝗦𝗣𝗢𝗡𝗦𝗢𝗥𝗘𝗗 Krka is one of the world’s leading generic pharmaceutical companies and is currently the fastest growing animal health company in the UK. With more than 50 years in developing animal health solutions Krka continues to bring innovation to the category with its branded generics covering key categories across parasite and infection control and pain management. Key ranges include Milprazon Chewable and Prinocate for parasite prevention and treatment in cats and dogs, and Tolracol for coccidiosis management in cows, sheep and pigs. Learn more about Krka Animal Health solutions at www.krka.co.uk

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related